key: cord-0963988-ite0xdv2 authors: Dwarka, Depika; Agoni, Clement; Mellem, John Jason; Soliman, Mahmoud E; Baijnath, Himansu title: Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches date: 2020-08-19 journal: S DOI: 10.1016/j.sajb.2020.07.035 sha: d9fabc26d8d15e45522cee6d244e8625d1e4949f doc_id: 963988 cord_uid: ite0xdv2 The coronavirus is a group of viruses found in animals as well as humans and have been detected since the 1960s. However, a newly identified form, SARS-CoV-2, has triggered a recent pandemic of respiratory disease now called COVID-19. There is currently no specific antiviral drug for the treatment of this pandemic, with most treatment strategies focused on symptomatic management and supportive therapy. As such, several drug discovery efforts are ongoing for potent treatment agents, with medicinal plants gradually gaining prominence. Approximately 80% of the South African population use traditional medicines to meet their primary health care needs. The current study aimed to identify potential COVID-19 therapeutic agents from a list of 29 bioactive compounds isolated from commonly used South African medicinal plants using molecular docking and molecular dynamics. Molecular docking identified arabic acid from Acacia senegal and L-canavanine found in Sutherlandia frutescens as a potential inhibitor of SARS-CoV-2 3C-like main protease. Similarly, hypoxoside isolated from Hypoxis hemerocallidea and uzarin from Xysmalobium undulatum, were identified as a potential inhibitor of SARS-CoV-2 receptor binding domain and SARS-CoV-2 RNA-dependent polymerase. These four bioactive compounds exhibited favourable binding orientations characterized by strong molecular interactions within respective inhibitors binding pockets of the target enzymes. Molecular dynamics simulations revealed that the binding of the identified inhibitors is characterized by structural perturbations which favour the inhibitory potency of these bioactive compounds. Additionally, in silico pharmacokinetic assessment of the compounds demonstrated favourable anti-SARS-CoV-2 properties. Although not conclusive, further experimental exploration of these compounds could serve as a starting point for the discovery of novel SARS-CoV-2 therapeutic Coronavirus 2 is a novel severe acute respiratory syndrome coronavirus. It was initially isolated from three people with pneumonia related to the pattern of acute respiratory illness cases in Wuhan (Spiteri et al., 2020 . Bioinformatic analysis of SARS-CoV-2 shows it is closely correlated to the original SARS-CoV . Now called SARS-CoV-2, phylogenetic analyses shows 96 % similarity of SARS-CoV-2 to the bat SARS-CoV (BatCov RaTG13), like zoonotic Betacoronavirus, it is expected that bats served as hosts for its precursor . Like other respiratory diseases, SARS-CoV-2, causes lung damage with inception of the disease possibly leading to progressive respiratory failure and even mortality due to alveolar damage . (Mehrbod et al., 2018) . There has been no report that has explored the possible therapeutic activity of South African medicinal plants against SARS-CoV-2. Therefore, this study is intended to evaluate the potency of compounds found in these plants to treat SARS-CoV-2. While traditional methods of drug discovery could take years, computational techniques aid in accelerating the drug discovery process. As such, this study seeks to employ in silico molecular docking models to investigate the possible inhibitory activity of some bioactive compounds isolated from some commonly used South African medicinal plants (Table 1) against SARS-CoV-2 RdRp, 3CL pro and SAR-CoV-2 RBD. These species were chosen based on their use for the common cold, flus, respiratory conditions, antimalarial, antiviral and antioxidant activity (Table 1) . For this study, three of the most extensively investigated therapeutic targets in SARS-CoV-2, whose X-ray crystal structures have been experimentally resolved were retrieved from the protein data bank (Berman et al., 2002 The active compounds of the medicinal plants selected for this study (Table 1) Avogadro was integrated with UFF force field and this force field was used to optimize the molecular geometries of the compounds and a steepest descent algorithm for structural minimization. The pdbqt formats of all the compounds were then generated using AutoDock Vina (Trott and Olson, 2010). The active site for SARS-CoV-2 RNA-dependent RNA polymerase and 3CL pro retrieved were mapped out using their experimental reported active site residue. The binding site of SARS- This was performed using the GPU version of AMBER 18 with an integrated PMEMD Using the LEAP module, hydrogen atoms were also added, while the entire system was neutralized by the addition of counter ions (Na+, Cl-) followed by a subsequent generation of ligand, protein and complex topologies as well as parameter files. The systems were explicitly solvated with water using the TIP3P orthorhombic box size of 7Å, which enclosed all atoms of the protein (Jorgensen et al., 1983 , Case et al., 2005 . Before running the LEAP module, the pdb4amber script was executed to protonate the histidine residues at a constant pH (cpH). This was appointed to automatically modify the protein system for use with LEAP. Both complexes were minimized initially for 2000 minimization steps applying a restraint potential of 500kcal/mol and then fully minimized for another 1000 steps of steepest descent without restrain. This was followed by the gradual thermalization of the systems with a temperature range of 0-300K for 50ps after which each system was equilibrated for 500ps while the temperature and pressure were kept constant at 300K and 1bar, respectively using the Berendsen barostat (Berendsen et al., 1984) . This was followed by MD production runs of 100ns for each system during which the SHAKE algorithm (Kräutler et al., 2001 ) was used to constrict all atomic hydrogen bonds. The MD simulation was initiated using a time step of 1fs and coordinates were saved at 1ps interval followed by subsequent analysis of trajectories using the integrated PTRJ and CPPTRAJ module (Roe et al., 2013) . Visualization of the complexes and data plots were carried out using the graphical user interface of UCSF chimera and Microcal origin analytical software, respectively (Seifert, 2014). To investigate the possibility of our selected bioactive compounds acting as potential therapeutic agents in the treatment of SARS-CoV-2 we performed molecular docking of the compounds against SARS-CoV-2 RdRp, 3CL pro and the SAR-CoV-2 RBD . The corresponding docking score of each compound as calculated is presented in Table 2 . As highlighted, arabic acid and L-canavanine exhibited the most favourable docking score of -5.2kcal/mol in binding to 3CL pro amongst all the compounds. Hypoxoside, exhibited the most favourable docking score of -6.9kcal/mol against SAR-CoV-2 RBD while uzarin exhibited the most favourable docking score of -3.5kcal/mol towards SARS-CoV-2 RdRp. Ipsenome -3.9 -4.1 -1.9 Rhinocerotinoic acid 5.9 -5.9 -3.4 Bilirubin 31.9 -6.8 -2.9 Piperitenone -2.9 -4.4 -2.7 To corroborate the possible binding of the leading docked bioactive compounds as shown in Table 2 , the intermolecular interactions between the bioactive compounds and their respective targeting enzymes were further analysed. Using LIGPLOT (Wallace et al., 1995) and Discovery studio (BIOVIA, 2015), two-dimensional as well as three-dimensional interactions were generated to visualize and compare the binding modes of these ligands. Figure 1 shows both arabic acid and L-canavanine engaged in strong interactions with binding site residues of 3CL pro . Notable interactions include hydrogen bonds with residues His163, Val308, Ser144, Leu141, Asn142, Gly143 and in Cys145 with arabic acid and residues Ser144, Cys145, Leu141, Asn142 and Glu166 with L-canavanine. The recurrence of residues Ser144, Cys145, Leu141 and Asn142 suggest they could be essential to inhibitor binding. It was also observed that both compounds are completely buried in the binding pocket of 3CL pro forming various interactions including the strong hydrogen bond interactions and hydrophobic interactions. These interactions anchor both compounds tightly to 3CL pro possibly accounting for the high docking score as observed for these compounds. The docking scores suggest that relative to the other bioactive compounds from the select In unravelling the conformational dynamics of 3CL pro upon the binding of arabic acid and Lcanavanine, the trajectories generated from the MD simulation were analysed using the post-MD techniques root mean square deviation (RMSD) (Pitera, 2014 , Maiorov, 1994 , root mean square fluctuation (RMSF) (Bornot et al., 2011 , Sneha, 2016 and radius of gyrations (ROG) (Lobanov et al., 2008) . The stability is of a tertiary protein structure is essential in the maintenance of the overall function of that protein. As such, we assessed the inhibitory impact of both arabic acid and L-canavanine upon binding to 3CL pro . As shown in Figure 4A , arabic acid bound 3CL pro exhibited a relatively lower root mean square deviation of c-α atoms in comparison with the unbound 3CL pro with and average RMSD value of 1.86Å and 3.67Å. This suggested a relatively more stable structural conformation of 3CL pro upon binding of arabic acid, thus a possible indication that the inhibitory mechanism of arabic acid towards Having exhibited favourable binding properties against 3CL pro , we also explored the possible structural and conformational changes that could accompany the possible therapeutic activity of L-canavanine. As shown in Figure 5A , the L-canavanine bound conformation exhibited an average RMSD of 4.76Å while the unbound model had an average RMSD of 3.67Å. This suggested that unlike arabic acid, L-canavanine induces an increase in the deviation of the c-α atoms as a possible mechanism of its inhibition. Also, a relatively higher average ROG of 22.27Å was exhibited by the L-canavanine bound 3CL pro in comparison with a lower average ROG in the unbound conformation of 22.16Å. This suggested a less compact 3CL pro upon Lcanavanine binding, consistent with structural disorientation as evidenced in the unstable bound enzyme conformation in the RMSD calculation. Interestingly, although some specific residue regions such as -110-135‖ of the bound conformation exhibited higher residue fluctuation than the unbound 3CL pro , the overall structurally flexibility of 3CL pro was higher in the unbound structure. The unbound exhibited an average RMSF of 11.50Å while the Lcanavanine bound structure exhibited an average RMSF of 9.11Å. Thus, L-canavanine inhibition of 3CL pro is characterized by a decrease in protein stability and compactness but with a decrease in overall residue flexibility. Structural and conformational changes associated with the binding of hypoxoside were also accessed and reported as shown in Figure 6 . From the RMSD assessment as shown in Figure 6A , hypoxoside binding is characterised by increase in the deviation of the c-α atoms of SARS-CoV-2 RBD with the bound conformation exhibiting an average RMSD of 6.12Å while the unbound showed an average RMSD of 5.97Å. An average ROG of 20.85Å was also estimated for the bound SARS-CoV-2 RBD while the unbound structure showcased an average ROG of 19.91Å as shown in Figure 6B . This indicated that the hypoxoside induces a less compact structure of SARS-CoV-2 RBD upon binding. As shown in Figure 6C Table 3 . Based on the brain or intestinal estimated permeation (BOILED-Egg) model, the SwissADME online platform was used to compute the lipophilicity (logP) and polarity of arabic acid, L-canavanine, hypoxoside and uzarin. LogP of compounds estimates their permeability across cellular membranes and could influence absorption as well as bioavailability of these compounds. According to Lipinski's Rule of 5, the calculated Log P (CLog P) of a compound intended for oral administration should not be greater than 5. As such, higher logP usually correlated with a compound with minimal potential of thus inferring hypoxoside and uzarin should be further investigated for their potential anti-SARS-CoV-2 properties. Also, with their large MW, a synthetic fragmentation of their structures to smaller more simpler compounds could increases the bioactivity and decrease toxicity . It is also important to note that uzarin, it is currently available as an over the counter drug for gastrointestinal problems. In all, it is evident that regardless if their incompliance with although they many drug-likeness rules, a further experimental evaluation of these compounds could yield very promising therapeutic agents. The aim of this study was to investigate the potential of the active compounds found in South African traditionally used plants against SARS-CoV-2. The compounds were tested in silico for the inhibition to 3CL pro , SARS-CoV-2 RBD and SARS-CoV-2 RdRp. Molecular docking revealed that four bioactive compounds from the 29 selected compounds exhibited potential of being investigated further as possible therapeutic agents against SARS-CoV-2. The bioactive compounds; arabic acid from Acacia senegal and L-canavanine found in Sutherlandia frutescens were shown to exhibit favourable binding modes in the active site of Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis Co-inhibition as a strategic therapeutic approach to overcome rifampin resistance in tuberculosis therapy: atomistic insights Synergistic interplay of the coadministration of rifampin and newly developed anti-TB drug: could it be a promising new line of TB therapy Human Rhinovirus Inhibition Through Capsid -Canyon‖ Perturbation: Structural Insights into The Role of a Novel Benzothiophene Derivative CF3-Pyridinyl Substitution on Antimalarial Therapeutics: Probing Differential Ligand Binding and Dynamical Inhibitory Effects of a Novel Triazolopyrimidine-Based Inhibitor on Plasmodium falciparum Dihydroorotate Dehydrogenase Morphological characterisation of the cell-growth inhibitory activity of rooperol and pharmacokinetic aspects of hypoxoside as an oral prodrug for cancer therapy Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs The proximal origin of SARS-CoV-2 The proximal origin of SARS-CoV-2 Comparative study on the antiviral activity of selected monoterpenes derived from essential oils Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro Molecular dynamics with coupling to an external bath The protein data bank Dassault Systèmes. Discovery Studio Modeling Environment Predicting protein flexibility through the prediction of local structures African herbal pharmacopoeia. Port Louis: Association for African Medicinal Plants Standards The Amber biomolecular simulation programs Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-CoV) Studies of South African medicinal plants Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease Avogadro: an advanced semantic chemical editor, visualization, and analysis platform Zulu medicinal plants: An inventory A second, non-canonical RNAdependent RNA polymerase in SARS Coronavirus Comparison of simple potential functions for simulating liquid water Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study Selective bronchodilatory effect of Rooibos tea (Aspalathus linearis) and its flavonoid, chrysoeriol Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors Pelargonium reniforme and Pelargonium sidoides: their botany, chemistry and medicinal use. Geranium and Pelargonium A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations Plant cardenolides in therapeutics The bioactivity of novel furanoterpenoids isolated from Siphonochilus aethiopicus Warburgia: A comprehensive review of the botany, traditional uses and phytochemistry Virostat (NA) NVQ, 1997. Method of treating viral infections Artemisia afra: a potential flagship for African medicinal plants? The crytal structure of 2019-nCoV main protease in complex with an inhibitor N3 Analysis of the inhibitory effect of canavanine on the replication of influenza RI/5+ virus I. Inhibition of assembly of RNP ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB Significance of root-mean-square deviation in comparing three-dimensional structures of globular proteins In silico identification of clinically approved medicines against the main protease of SARS-CoV-2, causative agent of covid-19 South African medicinal plant extracts active against influenza A virus Radius of gyration is indicator of compactness of protein structure Characterizing the ligandbinding landscape of Zika NS3 helicase-promising lead compounds as potential inhibitors Phytochemistry and ethnopharmacology of Lippia genus with a statement on chemotaxonomy and essential oil chemotypes Probing gallate-mediated selectivity and high-affinity binding of epigallocatechin gallate: A way-forward in the design of selective inhibitors for anti-apoptotic bcl-2 proteins Does Size Really Matter? Probing the Efficacy of Structural Reduction in the Optimization of Bioderived Compounds-A Computational -Proof-of-Concept‖ UCSF Chimera-a visualization system for exploratory research and analysis Expected distributions of root-mean-square positional deviations in proteins Antiviral activity of Aspalathus linearis against human influenza virus Assessment of anti HSV-1 activity of Aloe vera gel extract: an in vitro study Going global-Travel and the 2019 novel coronavirus. Travel medicine and infectious disease Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel medicine and infectious disease PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data Current updates on Centella asiatica: phytochemistry, pharmacology and traditional uses Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: An overview Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald OriginPro 9.1: Scientific Data Analysis and Graphing Software First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region AIDS herbal therapy SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets Medicinal plant use in the Bredasdorp/Elim region of the Southern Overberg in the Western Cape Province of South Africa Phytochemical and Antimicrobial Screening of Flavanones and Chalcones from Galenia africana and Dicerothamnus rhinocerotis AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus People's plants: A guide to useful plants of Southern Africa Medicinal plants of the world The potential of South African plants in the development of new medicinal products Xysmalobium undulatum (uzara)-review of an antidiarrhoeal traditional medicine LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein engineering, design and selection Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus Antechamber: an accessory software package for molecular mechanical calculations Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods A new coronavirus associated with human respiratory disease in China Structural basis for the recognition of the 2019-nCoV by human ACE2 The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor UCSF Chimera, MODELLER, and IMP: an integrated modeling system admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties Structural basis for inhibition of the RNAdependent RNA polymerase from SARS-CoV-2 by remdesivir A pneumonia outbreak associated with a new coronavirus of probable bat origin